|
An aggressive rapid prototyping plan was required to meet the development schedule for SPOT Vital Signs Lxi, a new Welch Allyn vital signs monitor. The aggressive schedule meant that portions of design, FDA approval, marketing, and pre-manufacturing would need to be performed in parallel.
|
|
|||||||||||||||||
|
|
||||||||||||||||||
|
||||||||||||||||||
